BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Provigil (Modafinil) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Provigil (Modafinil)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT01988883-5607@assetmemo.bio
DTSTAMP:20261121T004013Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Provigil (Modafinil): Phase 1 readout est. (NCT01988883)
DESCRIPTION:Provigil (Modafinil)\, phase 1.\nStudy: Modafinil and Cognitive
  Function in POTS\nEstimated primary completion: December 2026. This is a 
 ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can mo
 ve.\nDrug page: https://assetmemo.bio/drug/modafinil#upcoming-events\nRegi
 stry record: https://clinicaltrials.gov/study/NCT01988883
URL:https://assetmemo.bio/drug/modafinil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06041048-5607@assetmemo.bio
DTSTAMP:20261121T004013Z
DTSTART;VALUE=DATE:20261219
DTEND;VALUE=DATE:20261220
SUMMARY:Provigil (Modafinil): Phase 4 readout est. (NCT06041048)
DESCRIPTION:Provigil (Modafinil)\, phase 4.\nStudy: Investigation of Locus 
 Coeruleus Function in Sustained Attention\nEstimated primary completion: 1
 9 December 2026. This is a ClinicalTrials.gov estimate\, not a confirmed r
 eadout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/moda
 finil#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/N
 CT06041048
URL:https://assetmemo.bio/drug/modafinil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07582458-5607@assetmemo.bio
DTSTAMP:20261121T004013Z
DTSTART;VALUE=DATE:20270201
DTEND;VALUE=DATE:20270202
SUMMARY:Provigil (Modafinil): Phase 2/3 readout est. (NCT07582458)
DESCRIPTION:Provigil (Modafinil)\, phase 2/3.\nStudy: Modafinil for Debilit
 ating Fatigue in Quiescent Inflammatory Bowel Disease MODIFI-IBD Trial)\nE
 stimated primary completion: 1 February 2027. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/modafinil#upcoming-events\nRegistry record: https
 ://clinicaltrials.gov/study/NCT07582458
URL:https://assetmemo.bio/drug/modafinil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06354985-5607@assetmemo.bio
DTSTAMP:20261121T004013Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:Provigil (Modafinil): Phase 3 readout est. (NCT06354985)
DESCRIPTION:Provigil (Modafinil)\, phase 3.\nStudy: Modafinil and Exercise 
 for Post Stroke Fatigue\nEstimated primary completion: September 2027. Thi
 s is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it
  can move.\nDrug page: https://assetmemo.bio/drug/modafinil#upcoming-event
 s\nRegistry record: https://clinicaltrials.gov/study/NCT06354985
URL:https://assetmemo.bio/drug/modafinil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT05333250-5607@assetmemo.bio
DTSTAMP:20261121T004013Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:Provigil (Modafinil): Phase 1/2 readout est. (NCT05333250)
DESCRIPTION:Provigil (Modafinil)\, phase 1/2.\nStudy: Modafinil to Improve 
 Fatiguability\nEstimated primary completion: October 2027. This is a Clini
 calTrials.gov estimate\, not a confirmed readout date\, and it can move.\n
 Drug page: https://assetmemo.bio/drug/modafinil#upcoming-events\nRegistry 
 record: https://clinicaltrials.gov/study/NCT05333250
URL:https://assetmemo.bio/drug/modafinil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07295834-5607@assetmemo.bio
DTSTAMP:20261121T004013Z
DTSTART;VALUE=DATE:20271201
DTEND;VALUE=DATE:20271202
SUMMARY:Provigil (Modafinil): Phase 2 readout est. (NCT07295834)
DESCRIPTION:Provigil (Modafinil)\, phase 2.\nStudy: Modafinil For Fatigue i
 n IBD: A Feasibility Randomised Controlled Trial\nEstimated primary comple
 tion: 1 December 2027. This is a ClinicalTrials.gov estimate\, not a confi
 rmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dru
 g/modafinil#upcoming-events\nRegistry record: https://clinicaltrials.gov/s
 tudy/NCT07295834
URL:https://assetmemo.bio/drug/modafinil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07568574-5607@assetmemo.bio
DTSTAMP:20261121T004013Z
DTSTART;VALUE=DATE:20280501
DTEND;VALUE=DATE:20280502
SUMMARY:Provigil (Modafinil): Phase na readout est. (NCT07568574)
DESCRIPTION:Provigil (Modafinil)\, phase na.\nStudy: Impact of Medically Su
 pervised Performance-Enhancing Substances (PES) on Elite Athletes\nEstimat
 ed primary completion: 1 May 2028. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/modafinil#upcoming-events\nRegistry record: https://clinical
 trials.gov/study/NCT07568574
URL:https://assetmemo.bio/drug/modafinil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07887412-5607@assetmemo.bio
DTSTAMP:20261121T004013Z
DTSTART;VALUE=DATE:20290131
DTEND;VALUE=DATE:20290201
SUMMARY:Provigil (Modafinil): Phase 3 readout est. (NCT07887412)
DESCRIPTION:Provigil (Modafinil)\, phase 3.\nStudy: Efficacy and Safety of 
 Modafinil to Treat Fatigue in People With Mitochondrial Disease.\nEstimate
 d primary completion: 31 January 2029. This is a ClinicalTrials.gov estima
 te\, not a confirmed readout date\, and it can move.\nDrug page: https://a
 ssetmemo.bio/drug/modafinil#upcoming-events\nRegistry record: https://clin
 icaltrials.gov/study/NCT07887412
URL:https://assetmemo.bio/drug/modafinil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT00262470-5607@assetmemo.bio
DTSTAMP:20261121T004013Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:Provigil (Modafinil): Phase 1/2 readout est. (NCT00262470)
DESCRIPTION:Provigil (Modafinil)\, phase 1/2.\nStudy: Treatment of Orthosta
 tic Intolerance\nEstimated primary completion: December 2029. This is a Cl
 inicalTrials.gov estimate\, not a confirmed readout date\, and it can move
 .\nDrug page: https://assetmemo.bio/drug/modafinil#upcoming-events\nRegist
 ry record: https://clinicaltrials.gov/study/NCT00262470
URL:https://assetmemo.bio/drug/modafinil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07231497-5607@assetmemo.bio
DTSTAMP:20261121T004013Z
DTSTART;VALUE=DATE:20300430
DTEND;VALUE=DATE:20300501
SUMMARY:Provigil (Modafinil): Phase 3 readout est. (NCT07231497)
DESCRIPTION:Provigil (Modafinil)\, phase 3.\nStudy: Cognitive Strategies in
  Early Psychosis 1\nEstimated primary completion: 30 April 2030. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/modafinil#upcoming-events\nReg
 istry record: https://clinicaltrials.gov/study/NCT07231497
URL:https://assetmemo.bio/drug/modafinil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07263022-5607@assetmemo.bio
DTSTAMP:20261121T004013Z
DTSTART;VALUE=DATE:20300430
DTEND;VALUE=DATE:20300501
SUMMARY:Provigil (Modafinil): Phase 3 readout est. (NCT07263022)
DESCRIPTION:Provigil (Modafinil)\, phase 3.\nStudy: Cognitive Strategies in
  Early Psychosis 2\nEstimated primary completion: 30 April 2030. This is a
  ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can m
 ove.\nDrug page: https://assetmemo.bio/drug/modafinil#upcoming-events\nReg
 istry record: https://clinicaltrials.gov/study/NCT07263022
URL:https://assetmemo.bio/drug/modafinil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07895134-5607@assetmemo.bio
DTSTAMP:20261121T004013Z
DTSTART;VALUE=DATE:20311231
DTEND;VALUE=DATE:20320101
SUMMARY:Provigil (Modafinil): Phase 2 readout est. (NCT07895134)
DESCRIPTION:Provigil (Modafinil)\, phase 2.\nStudy: Psilocybin for Depressi
 on in Veterans\nEstimated primary completion: 31 December 2031. This is a 
 ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can mo
 ve.\nDrug page: https://assetmemo.bio/drug/modafinil#upcoming-events\nRegi
 stry record: https://clinicaltrials.gov/study/NCT07895134
URL:https://assetmemo.bio/drug/modafinil#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
